Subscribe to RSS

DOI: 10.1055/s-0045-1810106
Organoid-Based Models for Traumatic Brain Injury: Challenges, Innovations, and Future Perspectives
Funding None.

Abstract
Traumatic brain injury (TBI) is a major health concern impacting millions of individuals across the globe. Understanding how TBI damages the brain and finding better treatments are urgent needs. Traditional laboratory models, such as cell cultures and animal studies, often cannot fully represent the complex nature of human brain injuries. Recently, organoid-based models have become exciting new tools in brain research. These models are three-dimensional clusters of brain cells grown from human stem cells, which closely mimic the structure and function of the human brain. Because they come from human cells and grow in three dimensions, brain organoids provide a more accurate and detailed way to study how the brain develops and responds to injury compared with older methods. Brain organoids reproduce several essential characteristics of the developing human brain, making them highly valuable for scientific research. They allow scientists to explore the detailed processes involved in TBI and test new treatment approaches in a controlled laboratory setting. This flexibility and closeness to human biology make organoids a promising platform for advancing TBI research. In this review, we discuss the latest progress in using brain organoids to model TBI. We look at how well these models mimic the injury processes seen in real brain trauma and highlight both the challenges and future possibilities for improving and applying organoid-based models. Overall, organoid technology represents a significant step forward in understanding TBI and developing effective therapies.
Keywords
3D cell cultures - brain organoids - injury models - mechanical injury - traumatic brain injury (TBI)Publication History
Article published online:
19 August 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Weil ZM, Karelina K. Lifelong consequences of brain injuries during development: from risk to resilience. Front Neuroendocrinol 2019; 55: 100793
- 2 Mckee AC, Daneshvar DH. The neuropathology of traumatic brain injury. Handb Clin Neurol 2015; 127: 45-66
- 3 Capizzi A, Woo J, Verduzco-Gutierrez M. Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management. Med Clin North Am 2020; 104 (02) 213-238
- 4 Denniss RJ, Barker LA. Brain trauma and the secondary cascade in humans: review of the potential role of vitamins in reparative processes and functional outcome. Behav Sci (Basel) 2023; 13 (05) 388
- 5 Devi Y, Khan S, Rana P. et al; Deepak 3. Cognitive, behavioral, and functional impairments among traumatic brain injury survivors: impact on caregiver burden. J Neurosci Rural Pract 2020; 11 (04) 629-635
- 6 Freire MAM, Rocha GS, Bittencourt LO, Falcao D, Lima RR, Cavalcanti JRLP. Cellular and molecular pathophysiology of traumatic brain injury: what have we learned so far?. Biology (Basel) 2023; 12 (08) 1139
- 7 Ye Z, Li Z, Zhong S. et al. The recent two decades of traumatic brain injury: a bibliometric analysis and systematic review. Int J Surg 2024; 110 (06) 3745-3759
- 8 Balakin E, Yurku K, Fomina T. et al. A systematic review of traumatic brain injury in modern rodent models: current status and future prospects. Biology (Basel) 2024; 13 (10) 813
- 9 Liscovitch N, Chechik G. Specialization of gene expression during mouse brain development. PLOS Comput Biol 2013; 9 (09) e1003185
- 10 Housden BE, Perrimon N. Spatial and temporal organization of signaling pathways. Trends Biochem Sci 2014; 39 (10) 457-464
- 11 Jovanovich N, Habib A, Kodavali C, Edwards L, Amankulor N, Zinn PO. The evolving role of induced pluripotent stem cells and cerebral organoids in treating and modeling neurosurgical diseases. World Neurosurg 2021; 155: 171-179
- 12 Lovett ML, Nieland TJF, Dingle YL, Kaplan DL. Innovations in 3-dimensional tissue models of human brain physiology and diseases. Adv Funct Mater 2020; 30 (44) 1909146
- 13 Mutch CA, Talbott JF, Gean A. Imaging evaluation of acute traumatic brain injury. Neurosurg Clin N Am 2016; 27 (04) 409-439
- 14 Bisulli F, Muccioli L, Taruffi L. et al. Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study. Neurol Sci 2025; 46 (02) 527-538
- 15 Parker KN, Donovan MH, Smith K, Noble-Haeusslein LJ. Traumatic injury to the developing brain: emerging relationship to early life stress. Front Neurol 2021; 12: 708800
- 16 Wongsripuemtet P, Ohnuma T, Minic Z. et al. Early autonomic dysfunction in traumatic brain injury: an article review on the impact on multiple organ dysfunction. J Clin Med 2025; 14 (02) 557
- 17 Krishnamoorthy V, Komisarow JM, Laskowitz DT, Vavilala MS. Multiorgan dysfunction after severe traumatic brain injury: epidemiology, mechanisms, and clinical management. Chest 2021; 160 (03) 956-964
- 18 Ng SY, Lee AYW. Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci 2019; 13: 528
- 19 Meister MR, Boulter JH, Yabes JM. et al. Epidemiology of cranial infections in battlefield-related penetrating and open cranial injuries. J Trauma Acute Care Surg 2023; 95 (2S, suppl 1): S72-S78
- 20 Daneshvar DH, Riley DO, Nowinski CJ, McKee AC, Stern RA, Cantu RC. Long-term consequences: effects on normal development profile after concussion. Phys Med Rehabil Clin N Am 2011; 22 (04) 683-700 , ix
- 21 Rabinowitz AR, Levin HS. Cognitive sequelae of traumatic brain injury. Psychiatr Clin North Am 2014; 37 (01) 1-11
- 22 Al-Mufti F, Amuluru K, Changa A. et al. Traumatic brain injury and intracranial hemorrhage-induced cerebral vasospasm: a systematic review. Neurosurg Focus 2017; 43 (05) E14
- 23 Sahuquillo J, Dennis JA. Decompressive craniectomy for the treatment of high intracranial pressure in closed traumatic brain injury. Cochrane Database Syst Rev 2019; 12 (12) CD003983
- 24 DeWitt DS, Hawkins BE, Dixon CE. et al. Pre-clinical testing of therapies for traumatic brain injury. J Neurotrauma 2018; 35 (23) 2737-2754
- 25 Castiglione H, Vigneron PA, Baquerre C, Yates F, Rontard J, Honegger T. Human brain organoids-on-chip: advances, challenges, and perspectives for preclinical applications. Pharmaceutics 2022; 14 (11) 2301
- 26 Alciati A, Reggiani A, Caldirola D, Perna G. Human-induced pluripotent stem cell technology: toward the future of personalized psychiatry. J Pers Med 2022; 12 (08) 1340
- 27 Novelli G, Spitalieri P, Murdocca M, Centanini E, Sangiuolo F. Organoid factory: the recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine. Front Cell Dev Biol 2023; 10: 1059579
- 28 Qian X, Song H, Ming GL. Brain organoids: advances, applications and challenges. Development 2019; 146 (08) dev166074
- 29 Marie C, Pedard M, Quirié A. et al. Brain-derived neurotrophic factor secreted by the cerebral endothelium: a new actor of brain function?. J Cereb Blood Flow Metab 2018; 38 (06) 935-949
- 30 Fedele G, Cazzaniga A, Castiglioni S. et al. The presence of BBB hastens neuronal differentiation of cerebral organoids - the potential role of endothelial derived BDNF. Biochem Biophys Res Commun 2022; 626: 30-37
- 31 Kim SH, Chang MY. Application of human brain organoids-opportunities and challenges in modeling human brain development and neurodevelopmental diseases. Int J Mol Sci 2023; 24 (15) 12528
- 32 Jo J, Xiao Y, Sun AX. et al. Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and neuromelanin-producing neurons. Cell Stem Cell 2016; 19 (02) 248-257
- 33 Pavlinov I, Tambe M, Abbott J. et al. In depth characterization of midbrain organoids derived from wild type iPSC lines. PLoS One 2023; 18 (10) e0292926
- 34 Nishimura H, Li Y. Human pluripotent stem cell-derived models of the hippocampus. Int J Biochem Cell Biol 2024; 177: 106695
- 35 Chen Y, Bury LA, Chen F, Aldinger KA, Miranda HC, Wynshaw-Boris A. Generation of advanced cerebellar organoids for neurogenesis and neuronal network development. Hum Mol Genet 2023; 32 (18) 2832-2841
- 36 Xiang Y, Tanaka Y, Cakir B. et al. hESC-derived thalamic organoids form reciprocal projections when fused with cortical organoids. Cell Stem Cell 2019; 24 (03) 487-497.e7
- 37 Bhusal A, Rahman MH, Suk K. Hypothalamic inflammation in metabolic disorders and aging. Cell Mol Life Sci 2021; 79 (01) 32
- 38 Hyvärinen T, Hyysalo A, Kapucu FE. et al. Functional characterization of human pluripotent stem cell-derived cortical networks differentiated on laminin-521 substrate: comparison to rat cortical cultures. Sci Rep 2019; 9 (01) 17125
- 39 Jgamadze D, Johnson VE, Wolf JA. et al. Modeling traumatic brain injury with human brain organoids. Curr Opin Biomed Eng 2020; 14: 52-58
- 40 Shaikh S, Siddique L, Khalifey HT. et al. Brain organoid model systems of neurodegenerative diseases: recent progress and future prospects. Front Neurosci 2025; 19: 1604435
- 41 Ramirez S, Mukherjee A, Sepulveda S. et al. Modeling traumatic brain injury in human cerebral organoids. Cells 2021; 10 (10) 2683
- 42 Chen ZJ, Gillies GT, Broaddus WC. et al. A realistic brain tissue phantom for intraparenchymal infusion studies. J Neurosurg 2004; 101 (02) 314-322
- 43 Chwalek K, Tang-Schomer MD, Omenetto FG, Kaplan DL. In vitro bioengineered model of cortical brain tissue. Nat Protoc 2015; 10 (09) 1362-1373
- 44 Patterson LH, Walker JL, Rodriguez-Mesa E. et al. Investigating cellular response to impact with a microfluidic MEMS device. J Microelectromech Syst 2019; 28 (06) 1-11
- 45 Omelchenko A, Singh NK, Firestein BL. Current advances in in vitro models of central nervous system trauma. Curr Opin Biomed Eng 2020; 14: 34-41
- 46 Rosas-Hernandez H, Burks SM, Cuevas E, Ali SF. Stretch-induced deformation as a model to study dopaminergic dysfunction in traumatic brain injury. Neurochem Res 2019; 44 (11) 2546-2555
- 47 López-García I, Gerő D, Szczesny B. et al. Development of a stretch-induced neurotrauma model for medium-throughput screening in vitro: identification of rifampicin as a neuroprotectant. Br J Pharmacol 2018; 175 (02) 284-300
- 48 Hemphill MA, Dauth S, Yu CJ, Dabiri BE, Parker KK. Traumatic brain injury and the neuronal microenvironment: a potential role for neuropathological mechanotransduction. Neuron 2015; 85 (06) 1177-1192
- 49 Pilipović K, Harej Hrkać A, Kučić N, Mršić-Pelčić J. Modeling central nervous system injury in vitro: current status and promising future strategies. Biomedicines 2022; 11 (01) 94
- 50 Postolache TT, Wadhawan A, Can A. et al. Inflammation in traumatic brain injury. J Alzheimers Dis 2020; 74 (01) 1-28
- 51 Zhu H, Wang Z, Yu J. et al. Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage. Prog Neurobiol 2019; 178: 101610
- 52 Corrigan F, Mander KA, Leonard AV, Vink R. Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation. J Neuroinflammation 2016; 13 (01) 264
- 53 Davis CK, Jain SA, Bae ON, Majid A, Rajanikant GK. Hypoxia mimetic agents for ischemic stroke. Front Cell Dev Biol 2019; 6: 175
- 54 Gaston-Breton R, Maïza Letrou A, Hamoudi R, Stonestreet BS, Mabondzo A. Brain organoids for hypoxic-ischemic studies: from bench to bedside. Cell Mol Life Sci 2023; 80 (11) 318
- 55 Dasgupta I, Rangineni DP, Abdelsaid H, Ma Y, Bhushan A. Tiny organs, big impact: how microfluidic organ-on-chip technology is revolutionizing mucosal tissues and vasculature. Bioengineering (Basel) 2024; 11 (05) 476
- 56 Wysoczański B, Świątek M, Wójcik-Gładysz A. Organ-on-a-chip models-new possibilities in experimental science and disease modeling. Biomolecules 2024; 14 (12) 1569
- 57 Gangwal A, Lavecchia A. Artificial intelligence in preclinical research: enhancing digital twins and organ-on-chip to reduce animal testing. Drug Discov Today 2025; 30 (05) 104360
- 58 Giorgi C, Lombardozzi G, Ammannito F. et al. Brain organoids: a game-changer for drug testing. Pharmaceutics 2024; 16 (04) 443
- 59 Rauth S, Karmakar S, Batra SK, Ponnusamy MP. Recent advances in organoid development and applications in disease modeling. Biochim Biophys Acta Rev Cancer 2021; 1875 (02) 188527
- 60 Johnson VE, Stewart W, Smith DH. Axonal pathology in traumatic brain injury. Exp Neurol 2013; 246: 35-43
- 61 Bhatt M, Sharma M, Das B. The role of inflammatory cascade and reactive astrogliosis in glial scar formation post-spinal cord injury. Cell Mol Neurobiol 2024; 44 (01) 78
- 62 Kuo WT, Odenwald MA, Turner JR, Zuo L. Tight junction proteins occludin and ZO-1 as regulators of epithelial proliferation and survival. Ann N Y Acad Sci 2022; 1514 (01) 21-33
- 63 Sangobowale MA, Grin'kina NM, Whitney K. et al. Minocycline plus N-acetylcysteine reduce behavioral deficits and improve histology with a clinically useful time window. J Neurotrauma 2018; 35 (07) 907-917
- 64 Bellotti C, Samudyata S, Thams S, Sellgren CM, Rostami E. Organoids and chimeras: the hopeful fusion transforming traumatic brain injury research. Acta Neuropathol Commun 2024; 12 (01) 141
- 65 Tabatabaei Rezaei N, Kumar H, Liu H, Lee SS, Park SS, Kim K. Recent advances in organ-on-chips integrated with bioprinting technologies for drug screening. Adv Healthc Mater 2023; 12 (20) e2203172